Teneligliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor used in the management of type 2 diabetes mellitus to improve glycemic control by enhancing insulin secretion and suppressing glucagon release.… Read more


































![Chemical structure of 5-(4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl)-3-(thiazolidin-3-yl)tetrahydro-1H,3H-pyrrolo[1,2-c][1,3,2]oxazaborole, Sodium Salt](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F5-4-3-Methyl-1-phenyl-1H-pyrazol-5-ylpiperazin-1-yl-3-thiazolidin-3-yltetrahydro-1H3H-pyrrolo12-c132oxazaborole-Sodium-Salt.png&w=3840&q=75)
![Chemical structure of [(2S)-Tert-butyl4-hydroxy-2-(thiazolidine-3-carbonyl)pyrrolidine-1-carboxylate]](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2S-Tert-butyl4-hydroxy-2-thiazolidine-3-carbonylpyrrolidine-1-carboxylate.png&w=3840&q=75)














Teneligliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor used in the management of type 2 diabetes mellitus to improve glycemic control by enhancing insulin secretion and suppressing glucagon release. As a potent, pyrrolidine-based oral antidiabetic agent, its clinical application relies on rigorous quality standards to ensure safety and efficacy. Our comprehensive range of Teneligliptin-related compounds is essential for pharmaceutical laboratories conducting analytical testing, method validation, and quality control. This collection includes highly characterized reference standards, including various pharmacopeial and non-pharmacopeial impurities, to support precise impurity profiling and degradation product analysis. Additionally, we provide stable isotope labelled compounds, which are critical for accurate quantification and identification during complex bioanalytical studies such as LC-MS/MS. These high-quality materials enable researchers to comply with international regulatory guidelines, monitor drug stability, and maintain the highest levels of analytical integrity throughout the drug development lifecycle.